Rheumatoid Arthritis Clinical Trials in Houston

Showing 841-860 of 2,948 trials

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

NCT07123038

To assess the emergence, type, severity, and potential causality of delayed adverse events following administration of a gene-modified Treg therapeutic.

Rheumatoid Arthritis (RA)Hidradenitis Suppurativa (HS)

Sonoma Biotherapeutics, Inc.36 participantsStarted Jul 2025

San Francisco, California, United States • Stanford, California, United States • Aurora, Colorado, United States +7 more locations

COMPLETEDNA< 1 mile

Proton Beam Radiotherapy for Medulloblastoma and Pineoblastoma

NCT01063114

There are two types of external radiation treatments (proton beam and photon beam). As part of the participant's treatment, they will receive radiation to the entire central nervous system (CNS); this is known as craniospinal irradiation (CSI). In the past, photon radiation therapy has been used for CSI. In this study we will be examining the effects of proton beam radiation therapy. Studies have suggested that this kind of radiation can cause less damage to normal tissue than photon radiation therapy. The physical characteristics of proton beam radiation let the doctor safely deliver the amount of radiation delivered to the tumor that is normally delivered through standard therapy but spare more normal tissue in the process.

Brain TumorMedulloblastomaPineoblastoma

Massachusetts General Hospital90 participantsStarted Apr 2010

Boston, Massachusetts, United States • Houston, Texas, United States

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

Proton Beam Radiotherapy for Medulloblastoma and Pineoblastoma

Rheumatoid Arthritis Trials in Other Cities

Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events

A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

Hemodynamic-GUIDEd Management of Heart Failure

A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors

Proteomics of Brain Trauma-associated Elevated Intracranial Pressure (ICP)

Hepcidin Mimetic in Patients With Polycythemia Vera (REVIVE)

A Study of GC012F (AZD0120), a CAR T Therapy Targeting CD19 and BCMA in Subjects With Relapsed/Refractory Multiple Myeloma

To Assess the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa

Actis Total Hip System 2 Year Follow-up

A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Adults at High Risk of Severe RSV Disease

Safety and Efficacy of GSK Neisseria Gonorrhoeae GMMA (NgG) Investigational Vaccine When Administered to Healthy Adults 18 to 50 Years of Age.

A Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005)

LimiFlex Clinical Trial for the Treatment of Degenerative Spondylolisthesis With Spinal Stenosis

A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative Colitis

Air Optix Plus HydraGlyde Multifocal Daily/Extended Wear Contact Lenses

LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib

A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.

Other Conditions in Houston